Could someone explain more about the 52-week reference? I take it that as early as Q1 ‘22, if early results from Trial 3 are positive, they will start the FDA paperwork as they roll to the end of teh trial in ‘23. If that interpretation is correct, the real trigger point for us then is closer to 12 months away, not two years... This is clearly a stock for genuine long-term owners, not short-term renters...
Could someone explain more about the 52-week reference? I take...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $473.9M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 38.0¢ | $142.7K | 370.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49829 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 87450 | 3 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |